UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or
15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 17, 2008
FEDERAL HOME LOAN MORTGAGE CORPORATION
(Exact name of registrant as specified in its charter)
Freddie Mac
|
|
|
|
|
Federally chartered
corporation
|
|
000-53330
|
|
52-0904874
|
|
|
(State or other jurisdiction of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
8200 Jones Branch Drive
McLean, Virginia
|
|
22102
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(703) 903-2000
Not applicable
(Former name or former address, if changed since last
report)
Check the appropriate box below if the
Form 8-K
filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
o Soliciting
material pursuant to
Rule 14a-12
under the Exchange Act
(17 CFR 240.14a-12)
o Pre-commencement
communications pursuant to
Rule 14d-2(b)
under the Exchange Act
(17 CFR 240.14d-2(b))
o Pre-commencement
communications pursuant to
Rule 13e-4(c)
under the Exchange Act
(17 CFR 240.13e-4(c))
Item 3.01. Notice
of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing
(a) On November 17, 2008, Freddie Mac (formally, the
Federal Home Loan Mortgage Corporation) received a notice from
the New York Stock Exchange (the NYSE) that we had
failed to satisfy one of the NYSEs standards for continued
listing of our common stock. Specifically, the NYSE advised us
that we were below criteria for the Exchanges
price criteria for common stock because the average closing
price of our common stock over a consecutive
30-trading-day
period was less than $1.00 per share. As a result, the NYSE
informed us that we were not in compliance with the NYSEs
continued listing criteria under Section 802.01C of the
NYSE Listed Company Manual.
Under NYSE rules, we must notify the NYSE by December 2,
2008 of our intent to cure this deficiency by bringing the
common stock share price and average share price for 30
consecutive trading days above $1.00, or our common stock and
each of our listed series of preferred stock will be subject to
suspension and delisting procedures. If we notify the NYSE that
we intend to cure this deficiency, we will have six months from
November 17, 2008, subject to monitoring by the NYSE, to
cure the deficiency before the NYSE initiates suspension and
delisting procedures. We are currently working with our
Conservator, the Federal Housing Finance Agency, to explore
options relating to this deficiency and have not yet determined
our response or any specific action we will take as a result of
the Exchanges notice with respect to this deficiency.
Our common stock and the series of our preferred stock listed
for trading on the NYSE currently remain listed and continue to
trade on the NYSE under the symbol or prefix FRE,
but each will be assigned a .BC indicator by the
NYSE to signify that we are not currently in compliance with the
NYSEs quantitative continued listing standards.
On November 21, 2008, we issued a news release announcing
that we were not in compliance with the NYSEs continued
listing standards relating to minimum share price. The news
release, a copy of which is attached as Exhibit 99.1 to
this report, is incorporated into this report by reference.
Item 9.01. Financial
Statements and Exhibits
(d) Exhibits
The following exhibit is being filed as part of this Report on
Form 8-K:
|
|
|
|
|
|
Exhibit Number
|
|
Description of Exhibit
|
|
|
|
99.1
|
|
Press release dated November 21, 2008
|
|
|
|